Director, Comparative Effectiveness, Translational Research
Dr. Abiy Agiro specializes in clinical effectiveness to improve quality of care. As a Director of Research at HealthCore, Dr. Agiro leads a team of researchers responsible for identifying strategic trends in pharmaceutical drugs and nonpharmacological therapies for the development and execution of innovative studies to provide significant health economic impact to public and private payors.
Dr. Agiro has a decade of experience in health services research and comparative effectiveness studies in oncology, diabetes, cardiovascular disease and maternal/child health. His findings have been covered by national media and published in top-tier journals such as JAMA Internal Medicine, JAMA Oncology, JAMA Otolaryngology and JAMA Network Open.
Cardiac PET, an imaging test for evaluation of coronary artery disease, is advocated by some nuclear cardiologists for its high imaging quality. As with any more costly technology, it is important to ask: is the additional cost of PET offset by reduced downstream costs or better outcomes? According to the results of a new study published in the Journal of Nuclear Cardiology, the answer is no.
Reducing low-value services can help make healthcare more affordable over time without compromising the health outcomes of patients. The Choosing Wisely Campaign is a national initiative that seeks to advance a national dialogue on avoiding unnecessary medical tests, treatments, and procedures. HealthCore conducted a claims-based analysis to determine the effectiveness of this campaign on seven of the earliest low-value services.
Interview with Abiy Agiro, PhD, Director, Comparative Effectiveness, Translational Research at HealthCore, Inc.